MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head
← catalyst calendarNCT04003311 · readout in 710 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Enrolling by invitation
Study type
Observational
Enrollment
146estimated
Sites
4
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2019-12-13 | actual | When the study began enrolling |
| Primary completion | 2028-07-29 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-07-29 | estimated | The whole study's end, after follow-up |
| First posted | 2019-07-01 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-10-30 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Shoulder Pain
- Shoulder Injuries
- Shoulder Fractures
- Shoulder Disease
- Shoulder Arthritis
Interventions
- Device: Comprehensive Primary Micro Stem
- Device: Comprehensive Anatomic Versa-Dial Titanium Humeral Head
Primary outcome
what the primary-completion date above is the date OFDevice Safety assessed through the frequency and incidence of revisions, complications and Adverse Events
measured Out to 10 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed